Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) SHH

28.08

+0.87(+3.20%)

Updated at October 20 09:25AM

Currency In CNY

Valuation

Market Cap3.33B
Enterprise Value3.51B
P/E Ratio27.12
PEG Ratio-4.3
Price/Sales Ratio2.97
Price/Book Ratio2.21
Enterprise/Revenue3.18
Enterprise/EBITDA23.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.13

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue1.3B
Revenue/Share9.46
Gross Profit367.27M
EBITDA302.58M
Net Income146.42M
Diluted EPS1.08

Balance Sheet

Total Cash257.27M
Total Cash/Share1.9
Total Debt526.8M
Total Debt/Equity0.31
Current Ratio1.18
Book Value Per Share12.73

Price History

52-Week Change3.39
52-Week High33.34
52-Week Low19.97
Moving Average 50 Days28.73
Moving Average 200 Days27.18

Statistics

Average Volume1.55M
Shares Outstanding135.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield1.42
Payout Ratio0.49
Last Split Factor7:5
Last Split DateMay 27, 2020